Caseware UK (AP4) 2024.0.164 2024.0.164 2024-02-292024-02-29true2023-03-01falsePHarmacy55trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 08402763 2023-03-01 2024-02-29 08402763 2022-03-01 2023-02-28 08402763 2024-02-29 08402763 2023-02-28 08402763 c:Director1 2023-03-01 2024-02-29 08402763 c:Director2 2023-03-01 2024-02-29 08402763 d:PlantMachinery 2023-03-01 2024-02-29 08402763 d:PlantMachinery 2024-02-29 08402763 d:PlantMachinery 2023-02-28 08402763 d:PlantMachinery d:OwnedOrFreeholdAssets 2023-03-01 2024-02-29 08402763 d:FurnitureFittings 2023-03-01 2024-02-29 08402763 d:FurnitureFittings 2024-02-29 08402763 d:FurnitureFittings 2023-02-28 08402763 d:FurnitureFittings d:OwnedOrFreeholdAssets 2023-03-01 2024-02-29 08402763 d:OfficeEquipment 2023-03-01 2024-02-29 08402763 d:OfficeEquipment 2024-02-29 08402763 d:OfficeEquipment 2023-02-28 08402763 d:OfficeEquipment d:OwnedOrFreeholdAssets 2023-03-01 2024-02-29 08402763 d:OwnedOrFreeholdAssets 2023-03-01 2024-02-29 08402763 d:Goodwill 2023-03-01 2024-02-29 08402763 d:Goodwill 2024-02-29 08402763 d:Goodwill 2023-02-28 08402763 d:CurrentFinancialInstruments 2024-02-29 08402763 d:CurrentFinancialInstruments 2023-02-28 08402763 d:Non-currentFinancialInstruments 2024-02-29 08402763 d:Non-currentFinancialInstruments 2023-02-28 08402763 d:CurrentFinancialInstruments d:WithinOneYear 2024-02-29 08402763 d:CurrentFinancialInstruments d:WithinOneYear 2023-02-28 08402763 d:Non-currentFinancialInstruments d:AfterOneYear 2024-02-29 08402763 d:Non-currentFinancialInstruments d:AfterOneYear 2023-02-28 08402763 d:ShareCapital 2024-02-29 08402763 d:ShareCapital 2023-02-28 08402763 d:RetainedEarningsAccumulatedLosses 2024-02-29 08402763 d:RetainedEarningsAccumulatedLosses 2023-02-28 08402763 c:FRS102 2023-03-01 2024-02-29 08402763 c:AuditExemptWithAccountantsReport 2023-03-01 2024-02-29 08402763 c:FullAccounts 2023-03-01 2024-02-29 08402763 c:PrivateLimitedCompanyLtd 2023-03-01 2024-02-29 08402763 6 2023-03-01 2024-02-29 08402763 d:Goodwill d:OwnedIntangibleAssets 2023-03-01 2024-02-29 08402763 e:PoundSterling 2023-03-01 2024-02-29 iso4217:GBP xbrli:pure

Registered number: 08402763










BARAKAH HEALTHCARE LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 29 FEBRUARY 2024

 
BARAKAH HEALTHCARE LIMITED
 
  
CHARTERED ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF BARAKAH HEALTHCARE LIMITED
FOR THE YEAR ENDED 29 FEBRUARY 2024

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Barakah Healthcare Limited for the year ended 29 February 2024 which comprise the Balance sheet and the related notes from the Company's accounting records and from information and explanations you have given to us.
 

This report is made solely to the Board of Directors of Barakah Healthcare Limited, as a body, in accordance with the terms of our agreement. Our work has been undertaken solely to prepare for your approval the financial statements of Barakah Healthcare Limited and state those matters that we have agreed to state to them in this report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Barakah Healthcare Limited and its  Board of Directors, as a body, for our work or for this report.
 
 
It is your duty to ensure that Barakah Healthcare Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the Company's assets, liabilities, financial position and profit. You consider that Barakah Healthcare Limited is exempt from the statutory audit requirement for the year.
 
 
We have not been instructed to carry out an audit or review of the financial statements of Barakah Healthcare Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.





Shipleys Tax Planning

27 February 2025
Page 1

 
BARAKAH HEALTHCARE LIMITED
REGISTERED NUMBER: 08402763

BALANCE SHEET
AS AT 29 FEBRUARY 2024

29 February
28 February
2024
2023
Note
£
£

Fixed assets
  

Intangible assets
 4 
210,700
240,800

Tangible assets
 5 
915
3,448

Investments
 6 
50,000
-

  
261,615
244,248

Current assets
  

Stocks
  
39,943
40,034

Debtors: amounts falling due within one year
 7 
571,838
241,504

Cash at bank and in hand
 8 
103,506
211,083

  
715,287
492,621

Creditors: amounts falling due within one year
 9 
(783,774)
(789,726)

Net current liabilities
  
 
 
(68,487)
 
 
(297,105)

Total assets less current liabilities
  
193,128
(52,857)

Creditors: amounts falling due after more than one year
 10 
(180,310)
-

  

Net assets/(liabilities)
  
12,818
(52,857)


Capital and reserves
  

Called up share capital 
  
2
2

Profit and loss account
  
12,816
(52,859)

  
12,818
(52,857)


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on
Page 2

 
BARAKAH HEALTHCARE LIMITED
REGISTERED NUMBER: 08402763

BALANCE SHEET (CONTINUED)
AS AT 29 FEBRUARY 2024

27 February 2025.




Abdus Subhan
Mohammed Shajan Ali
Director
Director

The notes on pages 4 to 10 form part of these financial statements.

Page 3

 
BARAKAH HEALTHCARE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 29 FEBRUARY 2024

1.


General information

Barakah Healthcare Limited is a company domiciled in England & Wales, registration number 08402763. The registered office is Unit 3 Priory South Industrial Park, 11 Upper Priory Road, Northampton, NN1 2PT.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

Page 4

 
BARAKAH HEALTHCARE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 29 FEBRUARY 2024

2.Accounting policies (continued)

 
2.3

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

Benefits received and receivable as an incentive to sign an operating lease are recognised on a straight-line basis over the lease term, unless another systematic basis is representative of the time pattern of the lessee's benefit from the use of the leased asset.

 
2.4

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the Company in independently administered funds.

 
2.5

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.


 
2.6

Intangible assets

Goodwill

Goodwill represents the difference between amounts paid on the cost of a business combination and the acquirer’s interest in the fair value of its identifiable assets and liabilities of the acquiree at the date of acquisition. Subsequent to initial recognition, goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is amortised on a straight-line basis to the Statement of comprehensive income over its useful economic life.

Other intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

Page 5

 
BARAKAH HEALTHCARE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 29 FEBRUARY 2024

2.Accounting policies (continued)

 
2.7

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Plant and machinery
-
25%
Fixtures and fittings
-
25%
Office equipment
-
25%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.8

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

Investments in unlisted Company shares, whose market value can be reliably determined, are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in the Statement of comprehensive income for the period. Where market value cannot be reliably determined, such investments are stated at historic cost less impairment.

Investments in listed company shares are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in profit or loss for the period.

 
2.9

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a weighted average basis. Work in progress and finished goods include labour and attributable overheads.

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 
2.10

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Page 6

 
BARAKAH HEALTHCARE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 29 FEBRUARY 2024

2.Accounting policies (continued)

 
2.11

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.12

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


Employees

The average monthly number of employees, including directors, during the year was 5 (2023 - 5).


4.


Intangible assets






Goodwill

£



Cost


At 1 March 2023
301,000



At 29 February 2024

301,000



Amortisation


At 1 March 2023
60,200


Charge for the year on owned assets
30,100



At 29 February 2024

90,300



Net book value



At 29 February 2024
210,700



At 28 February 2023
240,800



Page 7

 
BARAKAH HEALTHCARE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 29 FEBRUARY 2024

5.


Tangible fixed assets







Plant and machinery
Fixtures and fittings
Office equipment
Total

£
£
£
£



Cost or valuation


At 1 March 2023
3,691
5,520
922
10,133



At 29 February 2024

3,691
5,520
922
10,133



Depreciation


At 1 March 2023
2,769
3,225
692
6,686


Charge for the year on owned assets
922
1,380
230
2,532



At 29 February 2024

3,691
4,605
922
9,218



Net book value



At 29 February 2024
-
915
-
915



At 28 February 2023
922
2,295
231
3,448


6.


Fixed asset investments








Investments in subsidiary companies

£



Cost or valuation


Additions
50,000



At 29 February 2024
50,000





7.


Debtors

29 February
28 February
2024
2023
£
£


Trade debtors
189,408
199,368

Other debtors
382,430
42,136
Page 8

 
BARAKAH HEALTHCARE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 29 FEBRUARY 2024

7.Debtors (continued)


571,838
241,504



8.


Cash and cash equivalents

29 February
28 February
2024
2023
£
£

Cash at bank and in hand
103,506
211,083

103,506
211,083



9.


Creditors: Amounts falling due within one year

29 February
28 February
2024
2023
£
£

Trade creditors
125,553
140,386

Corporation tax
12,593
6,244

Other taxation and social security
2,233
1,043

Other creditors
544,675
530,823

Accruals and deferred income
98,720
111,230

783,774
789,726



10.


Creditors: Amounts falling due after more than one year

29 February
28 February
2024
2023
£
£

Other creditors
180,310
-

180,310
-





11.


Pension commitments

Page 9

 
BARAKAH HEALTHCARE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 29 FEBRUARY 2024

12.


Related party transactions

During the year the company loaned £335,654 to Canons Pharmacy Ltd (2023: £Nil (a company in whch the directors Abdus Subhan and Mohammed Shajan Ali have an interest)).
At the balance sheet date, other creditors due after more than one year included £180,310 (2023: 300) owed to Barakah Holdings Ltd (a company owned by the directors Abdus Subhan and Mohammed Shajan Ali).
At the balance sheet date other creditors included £247,172 
(2023: £240,172) as amounted owed to the director Abdus Subhan.
At the balance sheet date other creditors included £257,269 
(2023: £250,269) as amounts owed to the director Mohammed Shajan Ali.


13.


Controlling party

The company is controlled by the directors Abdus Subhan and Mohammed Shajan Ali.


Page 10